2纖溶酶抑制物復(fù)合物(PIC)均顯著降低(P<0.05),且治療組的TAT、TM、PIC降低更明顯(P<0.05)。結(jié)論 益心舒膠囊聯(lián)合替格瑞洛片治療急性心肌梗死的療效確切,能提高心功能,降低血小板聚集率,調(diào)節(jié)血小板分泌,安全性良好。;Objective To investigate the clinical efficacy of Yixinshu Capsules combined with Ticagrelor Tablets in treatment of acute myocardial infarction. Methods Patients (90 cases) with acute myocardial infarction in Anyang Third People's Hospital from April 2020 to August 2021 were randomly divided into control and treatment groups, and each group had 44 cases. Patients in the control group were po administered with Ticagrelor Tablets, 90 mg/time, twice daily. Patients in the treatment group were po administered with Yixinshu Capsules on the basis of the control group, 1.2 g/time, three times daily. Patients in two groups were treated for 1 month. After treatment, the clinical efficacies were evaluated, and cardiac function index, platelet aggregation rate, and thrombus index in two groups were compared. Results After treatment, the total effective rate of the treatment group (88.64%) was higher than that of the control group (70.45%) (P < 0.05). After treatment, the LVEF and SV in two groups were significantly increased, but the E/Em in two groups were significantly decreased (P < 0.05). After treatment, the LVEF and SV in the treatment group were higher than those in the control group, but the E/Em in the treatment group was lower than those in the control group (P < 0.05). After treatment, the platelet aggregation rate of two groups were significantly decreased (P < 0.05), and the platelet aggregation rate of the treatment group was significantly lower than that of the control group (P < 0.05). After treatment, the TAT, TM, and PIC of two groups were significantly decreased (P < 0.05), and the TAT, TM, and PIC of the treatment group were significantly lower than those of the control group (P< 0.05). Conclusion Yixinshu Capsules combined with Ticagrelor Tablets is effective in treatment of acute myocardial infarction, which can improve cardiac function, reduce platelet aggregation rate, and regulate platelet secretion, with good drug safety."/>